Description
Dihexa is a synthetic, angiotensin IV–derived small peptide analogue investigated for its role in neurotrophic signaling and synaptic plasticity research. It is studied primarily for its interaction with the hepatocyte growth factor (HGF)/c-Met receptor system, a pathway known to regulate neuronal growth, dendritic branching, and synapse formation. Through modulation of this signaling cascade, Dihexa is examined in laboratory models for its effects on neurogenesis, synaptogenesis, and memory-related processes.
Preclinical research explores Dihexa’s potential to influence pathways associated with learning, memory consolidation, and neuronal survival, including mechanisms overlapping with brain-derived neurotrophic factor (BDNF) signaling. Animal studies have evaluated its activity in experimental models of neurodegeneration, traumatic brain injury, ischemic injury, and age-related cognitive decline. Its reported metabolic stability and central nervous system penetration make it a compound of interest strictly within in-vitro and preclinical research settings.
References:
Benoist CC et al., J Pharmacol Exp Ther, 2014;351(2):390–402
Wright JW et al., J Alzheimers Dis, 2015;45(4):985–1000
Sun X et al., Brain Sci, 2021;11(11):1487
These capsules are provided exclusively as inert containers for the dry transport, storage, and handling of laboratory research materials. They are not dosage forms and are not intended for ingestion or administration. They must not be used as drug delivery systems, consumed, or administered in any form. For Research Use Only: Not for use in humans or animals. Not for diagnostic or therapeutic purposes.
Reviews
There are no reviews yet.